Company: LHI
Filing Date: 2025-01-27
Form Type: DRS/A
Source: 0001213900-25-006939
Chunk: 244

Company: Living Homeopathy International Ltd.
Filing Date: 2025-01-27
Form: DRS/A
Chunk 244
---
2023, no
customer accounts for more than 10% of the Company’s revenue.

For the year ended March 31, 2024, three suppliers
accounted for approximately 41%, 22% and 20% of the total purchases. For the year ended March 31, 2023, four suppliers accounted for approximately
35%, 28%, 11% and 10% of the total purchases, respectively.

As ofMarch
31, 2024, one supplier accounted for approximately 96% of the Company’s prepayments to suppliers balance. As ofMarch 31, 2023, three suppliers accounted for approximately 37%, 37% and 25% of the Company’s prepayments to suppliers balance, respectively.

<div align='center'>F-14</div>

As ofMarch
31, 2024, one supplier accounted for approximately 90% of the Company’s accounts payable balance. As ofMarch 31, 2023, one supplier accounted for approximately 91% of the Company’s accounts payable balance, respectively.

The assets that are potentially subject to credit
risk mainly consist of cash and cash equivalents.

The Company believes that there is no significant
credit risk associated with cash in Hong Kong, which were held by reputable financial institutions in the jurisdiction where Living HK
is located. The Hong Kong Deposit Protection Board pays compensation up to a limit of HKD500,000 (approximately US$63,890) if a bank,
which an individual/a company deposits with, fails. As of March 31, 2024 and 2023, cash balance of $2,240,676 and $2,088,736 was maintained
at financial institutions in Hong Kong and approximately $74,866 and $137,902 was insured by the Hong Kong Deposit Protection Board, respectively.

The Company is exposed to cash flow interest rate
risk through the changes in interest rates related mainly to the Company’s bank borrowings and bank balances. The Company currently
does not have any interest rate hedging policy in relation to fair value interest rate risk and cash flow interest rate risk. The Company
monitor its exposures on an ongoing basis and will consider hedging the interest rate should the need arises.

The Company is exposed to foreign currency risk
primarily through purchases that are denominated in a currency other than the functional currency of the operations to which they relate.
The currencies giving rise to this risk are primarily US$. As HKD is currently pegged to US$, our exposure